GENEVA, July 18 -- SHANGHAI WORLD LEADER PHARMACEUTICAL CO., LTD. filed a patent application (CN2026/072119) for “FORMULATED COMPOSITION OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST FOR NASAL ADMINISTRATION, METHOD FOR PREPARING SAME, USE THEREOF, AND NASAL APPLICATOR”. With publication no. WO/2026/149584, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/26

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....